Wednesday, 20 January 2021

MDR/IVDR Market surveillance

Market surveillance activities are performed by competent authority to ensure that device meets the MDR.

CA shall perform appropriate checks on the conformity characteristics and performance of devices.it will review the documentation and physical or laboratory checks based on adequate samples.

Every CA shall allocate an enough material and competent human resources in order to carry out those activities and prepare annual summary activity plans.

CA shall prepare an annual summary of the results of their surveillance activities and make it accessible to other competent authorities through Electronic system on market surveillance.

Flow :

CA Prepare annual summary activity plans—Medical device inspection to verify MDR compliance –Inform economic operator & get comments from them –CA will upload the report in electronic system.

Member states will check the CA market surveillance activities at least every four years and the results shall be communicated to the other Member States and the Commission.

Article 94 discuss that CA shall evaluate the devices that may present an unacceptable risk to the health or safety of patients, users or other persons, or to other aspects of the protection of public health; or otherwise does not comply with MDR.

Economic operators need to take appropriate and duly justified corrective action to bring the device to compliance with MDR.if not, CA will perform below actions (MDR Article 95 & 97/IVDR Article 91 & 92))

·       Restrict the making available of the device on the market

·       Making available of the device to specific requirements

·       Device withdrawal

·       Device recall

References

REGULATION (EU) 2017/745 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC

REGULATION (EU) 2017/746 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU


No comments:

Post a Comment